Tapewire

Nasdaq · USD

MAZE

Maze Therapeutics, Inc.

Export transactions ↓
Tapewire entity
1775
SEC CIK
0001842295
Parsed reports
106

Last 12 months

Inside the activity.

0 purchase rows · 95 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202508
Jan 2026011
Feb 202609
Mar 202609
Apr 202606
May 202607
Jun 202608
Jul 202607
Aug 202606
Sep 2026021
Oct 202603

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
July 29, 2026 Filed Jul 31, 2026 20:15 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 7,500 $0.00 Strike: $10.42 $0.00
Disclosure

SEC source: 0002050167-26-000019 · form4-07312026_080715.xml · derivative · entry 4

Dandekar Atul · CIK 0002050167 · CSBO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 21,643

Underlying: Common Stock · 7,500 shares

Expires 2031-04-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.

F4 · derivative.exercise_date: The option is fully vested. Pursuant to the terms of the reporting person's award agreement with the Issuer, the award became fully vested on March 17, 2025.

Read SEC document
July 29, 2026 Filed Jul 31, 2026 20:15 UTC SaleCommon Stock 400 $27.89 $11,156.00
Disclosure

SEC source: 0002050167-26-000019 · form4-07312026_080715.xml · nonDerivative · entry 3

Dandekar Atul · CIK 0002050167 · CSBO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 26,250

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.

F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.81 to $27.96 per share, inclusive.

Read SEC document
July 29, 2026 Filed Jul 31, 2026 20:15 UTC SaleCommon Stock 7,100 $27.31 $193,875.44
Disclosure

SEC source: 0002050167-26-000019 · form4-07312026_080715.xml · nonDerivative · entry 2

Dandekar Atul · CIK 0002050167 · CSBO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 26,650

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.

F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.81 to $27.79 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnote 3 of this Form 4.

Read SEC document
July 29, 2026 Filed Jul 31, 2026 20:15 UTC Exercise / conversionCommon Stock 7,500 $10.42 $78,150.00
Disclosure

SEC source: 0002050167-26-000019 · form4-07312026_080715.xml · nonDerivative · entry 1

Dandekar Atul · CIK 0002050167 · CSBO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 33,750

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.

Read SEC document
July 01, 2026 Filed Jul 2, 2026 20:29 UTC
Bernstein HaroldPresident, R&D & CMO
Exercise / conversionStock Option (Right to Buy) · Derivative 14,609 $0.00 Strike: $10.42 $0.00
Disclosure

SEC source: 0002050172-26-000025 · form4-07022026_080753.xml · derivative · entry 4

Bernstein Harold · CIK 0002050172 · President, R&D & CMO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 192,945

Underlying: Common Stock · 14,609 shares

Expires 2032-10-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.

F4 · derivative.exercise_date: The option vested as to 1/4th of the total award on October 3, 2023, and thereafter vested or vests as to 1/48th of the total award on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date.

Read SEC document
July 01, 2026 Filed Jul 2, 2026 20:29 UTC
Bernstein HaroldPresident, R&D & CMO
SaleCommon Stock 1,200 $30.34 $36,404.28
Disclosure

SEC source: 0002050172-26-000025 · form4-07022026_080753.xml · nonDerivative · entry 3

Bernstein Harold · CIK 0002050172 · President, R&D & CMO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.

F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.24 to $30.42 per share, inclusive.

Read SEC document
July 01, 2026 Filed Jul 2, 2026 20:29 UTC
Bernstein HaroldPresident, R&D & CMO
SaleCommon Stock 13,409 $29.87 $400,459.79
Disclosure

SEC source: 0002050172-26-000025 · form4-07022026_080753.xml · nonDerivative · entry 2

Bernstein Harold · CIK 0002050172 · President, R&D & CMO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,200

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.

F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.24 to $30.23 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnote 3 of this Form 4.

Read SEC document
July 01, 2026 Filed Jul 2, 2026 20:29 UTC
Bernstein HaroldPresident, R&D & CMO
Exercise / conversionCommon Stock 14,609 $10.42 $152,225.78
Disclosure

SEC source: 0002050172-26-000025 · form4-07022026_080753.xml · nonDerivative · entry 1

Bernstein Harold · CIK 0002050172 · President, R&D & CMO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 14,609

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.

Read SEC document
July 01, 2026 Filed Jul 2, 2026 20:28 UTC
Coloma Jason VDirector · Chief Executive Officer
SaleCommon Stock 1,597 $30.44 $48,606.13
Disclosure

SEC source: 0001676170-26-000014 · form4-07022026_080737.xml · nonDerivative · entry 3

Coloma Jason V · CIK 0001676170 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · Coloma Family Trust

Disclosed balance after: 287,171

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026.

F6 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.385 to $30.49 per share, inclusive.

F5 · ownership.nature: These securities are directly held by the Coloma Family Trust (the "Family Trust"), for which the reporting person and his spouse serve as co-trustees.

Read SEC document
July 01, 2026 Filed Jul 2, 2026 20:28 UTC
Coloma Jason VDirector · Chief Executive Officer
SaleCommon Stock 30,311 $29.95 $907,920.54
Disclosure

SEC source: 0001676170-26-000014 · form4-07022026_080737.xml · nonDerivative · entry 2

Coloma Jason V · CIK 0001676170 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · Coloma Family Trust

Disclosed balance after: 288,768

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026.

F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.375 to $30.37 per share, inclusive.

F5 · ownership.nature: These securities are directly held by the Coloma Family Trust (the "Family Trust"), for which the reporting person and his spouse serve as co-trustees.

Read SEC document
July 01, 2026 Filed Jul 2, 2026 20:28 UTC
Coloma Jason VDirector · Chief Executive Officer
SaleCommon Stock 2,593 $29.98 $77,726.21
Disclosure

SEC source: 0001676170-26-000014 · form4-07022026_080737.xml · nonDerivative · entry 1

Coloma Jason V · CIK 0001676170 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · The Coloma 2021 Irrevocable Trust

Disclosed balance after: 23,337

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026.

F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.455 to $30.38 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnotes 4 and 6 of this Form 4.

F3 · ownership.nature: These securities are directly held by The Coloma 2021 Irrevocable Trust (the "Irrevocable Trust"), for which the reporting person and his spouse serve as co-trustees.

Read SEC document
June 29, 2026 Filed Jul 1, 2026 20:17 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 7,500 $0.00 Strike: $10.42 $0.00
Disclosure

SEC source: 0002050167-26-000016 · form4-07012026_080715.xml · derivative · entry 3

Dandekar Atul · CIK 0002050167 · CSBO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 29,143

Underlying: Common Stock · 7,500 shares

Expires 2031-04-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.

F3 · derivative.exercise_date: The option is fully vested. Pursuant to the terms of the reporting person's award agreement with the Issuer, the award became fully vested on March 17, 2025.

Read SEC document
June 29, 2026 Filed Jul 1, 2026 20:17 UTC SaleCommon Stock 7,500 $28.02 $210,150.00
Disclosure

SEC source: 0002050167-26-000016 · form4-07012026_080715.xml · nonDerivative · entry 2

Dandekar Atul · CIK 0002050167 · CSBO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 26,250

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.

Read SEC document
June 29, 2026 Filed Jul 1, 2026 20:17 UTC Exercise / conversionCommon Stock 7,500 $10.42 $78,150.00
Disclosure

SEC source: 0002050167-26-000016 · form4-07012026_080715.xml · nonDerivative · entry 1

Dandekar Atul · CIK 0002050167 · CSBO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 33,750

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.

F2 · balance_after: The reported total includes 1,442 shares of the Issuer's Common Stock acquired by the reporting person in one or more transactions with the Issuer pursuant to its Employee Stock Purchase Plan, which transactions are exempt pursuant to Rules 16a3(f)(1)(i)(B) and 16b3(c).

Read SEC document
June 23, 2026 Filed Jun 24, 2026 20:14 UTC
Coloma Jason VDirector · Chief Executive Officer
SaleCommon Stock 23,865 $26.05 $621,673.70
Disclosure

SEC source: 0001676170-26-000012 · form4-06242026_080649.xml · nonDerivative · entry 3

Coloma Jason V · CIK 0001676170 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · Coloma Family Trust

Disclosed balance after: 319,079

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026.

F5 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.00 to $26.185 per share, inclusive.

F3 · ownership.nature: These securities are directly held by the Coloma Family Trust (the "Family Trust"), for which the reporting person and his spouse serve as co-trustees.

Read SEC document
June 22, 2026 Filed Jun 24, 2026 20:14 UTC
Coloma Jason VDirector · Chief Executive Officer
SaleCommon Stock 2,040 $26.00 $53,040.00
Disclosure

SEC source: 0001676170-26-000012 · form4-06242026_080649.xml · nonDerivative · entry 2

Coloma Jason V · CIK 0001676170 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · The Coloma 2021 Irrevocable Trust

Disclosed balance after: 25,930

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026.

F4 · ownership.nature: These securities are directly held by The Coloma 2021 Irrevocable Trust (the "Irrevocable Trust"), for which the reporting person and his spouse serve as co-trustees.

Read SEC document
June 22, 2026 Filed Jun 24, 2026 20:14 UTC
Coloma Jason VDirector · Chief Executive Officer
SaleCommon Stock 1,953 $26.00 $50,780.93
Disclosure

SEC source: 0001676170-26-000012 · form4-06242026_080649.xml · nonDerivative · entry 1

Coloma Jason V · CIK 0001676170 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · Coloma Family Trust

Disclosed balance after: 342,944

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026.

F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.00 to $26.025 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnote 5 of this Form 4.

F3 · ownership.nature: These securities are directly held by the Coloma Family Trust (the "Family Trust"), for which the reporting person and his spouse serve as co-trustees.

Read SEC document
June 08, 2026 Filed Jun 10, 2026 20:23 UTC GrantStock Option (Right to Buy) · Derivative 18,000 $0.00 Strike: $23.58 $0.00
Disclosure

SEC source: 0001804999-26-000002 · form4-06102026_080643.xml · derivative · entry 1

Andrews Nancy C · CIK 0001804999 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,000

Underlying: Common Stock · 18,000 shares

Expires 2036-06-07

F1 · derivative.exercise_date: The option shall vest and be fully exercisable on the earlier of (i) the date of the issuer's 2027 annual stockholders meeting or (ii) June 8, 2027, subject to the reporting person's continued service to the issuer on the vesting date.

Read SEC document
June 08, 2026 Filed Jun 10, 2026 20:28 UTC GrantStock Option (Right to Buy) · Derivative 18,000 $0.00 Strike: $23.58 $0.00
Disclosure

SEC source: 0001283290-26-000002 · form4-06102026_080618.xml · derivative · entry 1

Lim Jonathan E · CIK 0001283290 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,000

Underlying: Common Stock · 18,000 shares

Expires 2036-06-07

F1 · derivative.exercise_date: The option shall vest and be fully exercisable on the earlier of (i) the date of the issuer's 2027 annual stockholders meeting or (ii) June 8, 2027, subject to the reporting person's continued service to the issuer on the vesting date.

Read SEC document
June 08, 2026 Filed Jun 10, 2026 20:31 UTC GrantStock Option (Right to Buy) · Derivative 18,000 $0.00 Strike: $23.58 $0.00
Disclosure

SEC source: 0001238403-26-000004 · form4-06102026_080629.xml · derivative · entry 1

SPIEGELMAN DANIEL K · CIK 0001238403 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,000

Underlying: Common Stock · 18,000 shares

Expires 2036-06-07

F1 · derivative.exercise_date: The option shall vest and be fully exercisable on the earlier of (i) the date of the issuer's 2027 annual stockholders meeting or (ii) June 8, 2027, subject to the reporting person's continued service to the issuer on the vesting date.

Read SEC document
June 08, 2026 Filed Jun 10, 2026 20:25 UTC GrantStock Option (Right to Buy) · Derivative 18,000 $0.00 Strike: $23.58 $0.00
Disclosure

SEC source: 0001192591-26-000004 · form4-06102026_080626.xml · derivative · entry 1

HOMCY CHARLES J · CIK 0001192591 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,000

Underlying: Common Stock · 18,000 shares

Expires 2036-06-07

F1 · derivative.exercise_date: The option shall vest and be fully exercisable on the earlier of (i) the date of the issuer's 2027 annual stockholders meeting or (ii) June 8, 2027, subject to the reporting person's continued service to the issuer on the vesting date.

Read SEC document
June 08, 2026 Filed Jun 10, 2026 20:30 UTC GrantStock Option (Right to Buy) · Derivative 18,000 $0.00 Strike: $23.58 $0.00
Disclosure

SEC source: 0001214133-26-000002 · form4-06102026_080600.xml · derivative · entry 1

SCHELLER RICHARD H · CIK 0001214133 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,000

Underlying: Common Stock · 18,000 shares

Expires 2036-06-07

F1 · derivative.exercise_date: The option shall vest and be fully exercisable on the earlier of (i) the date of the issuer's 2027 annual stockholders meeting or (ii) June 8, 2027, subject to the reporting person's continued service to the issuer on the vesting date.

Read SEC document
June 08, 2026 Filed Jun 10, 2026 20:26 UTC GrantStock Option (Right to Buy) · Derivative 18,000 $0.00 Strike: $23.58 $0.00
Disclosure

SEC source: 0001596492-26-000007 · form4-06102026_080650.xml · derivative · entry 1

Hoppenot Herve · CIK 0001596492 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,000

Underlying: Common Stock · 18,000 shares

Expires 2036-06-07

F1 · derivative.exercise_date: The option shall vest and be fully exercisable on the earlier of (i) the date of the issuer's 2027 annual stockholders meeting or (ii) June 8, 2027, subject to the reporting person's continued service to the issuer on the vesting date.

Read SEC document
June 01, 2026 Filed Jun 3, 2026 21:01 UTC
Bernstein HaroldPresident, R&D & CMO
Exercise / conversionStock Option (Right to Buy) · Derivative 14,853 $0.00 Strike: $10.42 $0.00
Disclosure

SEC source: 0002050172-26-000023 · form4-06032026_090633.xml · derivative · entry 4

Bernstein Harold · CIK 0002050172 · President, R&D & CMO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 207,554

Underlying: Common Stock · 14,853 shares

Expires 2032-10-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.

F4 · derivative.exercise_date: The option vested as to 1/4th of the total award on October 3, 2023, and thereafter vested or vests as to 1/48th of the total award on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date.

Read SEC document
June 01, 2026 Filed Jun 3, 2026 21:01 UTC
Bernstein HaroldPresident, R&D & CMO
SaleCommon Stock 1,600 $26.36 $42,172.16
Disclosure

SEC source: 0002050172-26-000023 · form4-06032026_090633.xml · nonDerivative · entry 3

Bernstein Harold · CIK 0002050172 · President, R&D & CMO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.

F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.16 to $26.53 per share, inclusive.

Read SEC document
June 01, 2026 Filed Jun 3, 2026 21:01 UTC
Bernstein HaroldPresident, R&D & CMO
SaleCommon Stock 13,253 $25.57 $338,940.17
Disclosure

SEC source: 0002050172-26-000023 · form4-06032026_090633.xml · nonDerivative · entry 2

Bernstein Harold · CIK 0002050172 · President, R&D & CMO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,600

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.

F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.16 to $26.10 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnote 3 of this Form 4.

Read SEC document
June 01, 2026 Filed Jun 3, 2026 21:01 UTC
Bernstein HaroldPresident, R&D & CMO
Exercise / conversionCommon Stock 14,853 $10.42 $154,768.26
Disclosure

SEC source: 0002050172-26-000023 · form4-06032026_090633.xml · nonDerivative · entry 1

Bernstein Harold · CIK 0002050172 · President, R&D & CMO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 14,853

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.

Read SEC document
June 01, 2026 Filed Jun 3, 2026 21:04 UTC
Coloma Jason VDirector · Chief Executive Officer
SaleCommon Stock 553 $26.24 $14,511.38
Disclosure

SEC source: 0001676170-26-000009 · form4-06032026_090612.xml · nonDerivative · entry 2

Coloma Jason V · CIK 0001676170 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · The Coloma 2021 Irrevocable Trust

Disclosed balance after: 27,970

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026.

F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.00 to $26.50 per share, inclusive.

F5 · ownership.nature: These securities are directly held by The Coloma 2021 Irrevocable Trust (the "Irrevocable Trust"), for which the reporting person and his spouse serve as co-trustees.

Read SEC document
June 01, 2026 Filed Jun 3, 2026 21:04 UTC
Coloma Jason VDirector · Chief Executive Officer
SaleCommon Stock 6,090 $26.20 $159,536.69
Disclosure

SEC source: 0001676170-26-000009 · form4-06032026_090612.xml · nonDerivative · entry 1

Coloma Jason V · CIK 0001676170 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · Coloma Family Trust

Disclosed balance after: 344,897

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026.

F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.00 to $26.545 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnote 4 of this Form 4.

F3 · ownership.nature: These securities are directly held by the Coloma Family Trust (the "Family Trust"), for which the reporting person and his spouse serve as co-trustees.

Read SEC document
May 29, 2026 Filed Jun 2, 2026 20:12 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 7,500 $0.00 Strike: $10.42 $0.00
Disclosure

SEC source: 0002050167-26-000013 · form4-06022026_080603.xml · derivative · entry 3

Dandekar Atul · CIK 0002050167 · CSBO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 36,643

Underlying: Common Stock · 7,500 shares

Expires 2031-04-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.

F3 · derivative.exercise_date: The option is fully vested. Pursuant to the terms of the reporting person's award agreement with the Issuer, the award became fully vested on March 17, 2025.

Read SEC document
May 29, 2026 Filed Jun 2, 2026 20:12 UTC SaleCommon Stock 7,500 $26.34 $197,553.75
Disclosure

SEC source: 0002050167-26-000013 · form4-06022026_080603.xml · nonDerivative · entry 2

Dandekar Atul · CIK 0002050167 · CSBO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 24,808

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.

F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.03 to $26.64 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
May 29, 2026 Filed Jun 2, 2026 20:12 UTC Exercise / conversionCommon Stock 7,500 $10.42 $78,150.00
Disclosure

SEC source: 0002050167-26-000013 · form4-06022026_080603.xml · nonDerivative · entry 1

Dandekar Atul · CIK 0002050167 · CSBO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 32,308

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.

Read SEC document
May 26, 2026 Filed May 27, 2026 20:16 UTC
Coloma Jason VDirector · Chief Executive Officer
SaleCommon Stock 25,582 $26.02 $665,515.73
Disclosure

SEC source: 0001676170-26-000007 · form4-05272026_080518.xml · nonDerivative · entry 3

Coloma Jason V · CIK 0001676170 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · Coloma Family Trust

Disclosed balance after: 350,987

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026.

F5 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.00 to $26.09 per share, inclusive.

F3 · ownership.nature: These securities are directly held by the Coloma Family Trust (the "Family Trust"), for which the reporting person and his spouse serve as co-trustees.

Read SEC document
May 22, 2026 Filed May 27, 2026 20:16 UTC
Coloma Jason VDirector · Chief Executive Officer
SaleCommon Stock 2,478 $26.00 $64,428.00
Disclosure

SEC source: 0001676170-26-000007 · form4-05272026_080518.xml · nonDerivative · entry 2

Coloma Jason V · CIK 0001676170 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · The Coloma 2021 Irrevocable Trust

Disclosed balance after: 28,523

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026.

F4 · ownership.nature: These securities are directly held by The Coloma 2021 Irrevocable Trust (the "Irrevocable Trust"), for which the reporting person and his spouse serve as co-trustees.

Read SEC document
May 22, 2026 Filed May 27, 2026 20:16 UTC
Coloma Jason VDirector · Chief Executive Officer
SaleCommon Stock 4,504 $26.00 $117,104.45
Disclosure

SEC source: 0001676170-26-000007 · form4-05272026_080518.xml · nonDerivative · entry 1

Coloma Jason V · CIK 0001676170 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · Coloma Family Trust

Disclosed balance after: 376,569

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026.

F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.00 to $26.105 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnote 5 of this Form 4.

F3 · ownership.nature: These securities are directly held by the Coloma Family Trust (the "Family Trust"), for which the reporting person and his spouse serve as co-trustees.

Read SEC document
May 15, 2026 Filed May 18, 2026 21:07 UTC
Coloma Jason VDirector · Chief Executive Officer
SaleCommon Stock 116 $26.00 $3,016.00
Disclosure

SEC source: 0001676170-26-000004 · form4-05182026_090526.xml · nonDerivative · entry 2

Coloma Jason V · CIK 0001676170 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · The Coloma 2021 Irrevocable Trust

Disclosed balance after: 31,001

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026.

F3 · ownership.nature: These securities are directly held by The Coloma 2021 Irrevocable Trust (the "Irrevocable Trust"), for which the reporting person and his spouse serve as co-trustees.

Read SEC document
May 15, 2026 Filed May 18, 2026 21:07 UTC
Coloma Jason VDirector · Chief Executive Officer
SaleCommon Stock 1,822 $26.00 $47,372.00
Disclosure

SEC source: 0001676170-26-000004 · form4-05182026_090526.xml · nonDerivative · entry 1

Coloma Jason V · CIK 0001676170 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · Coloma Family Trust

Disclosed balance after: 381,073

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026.

F2 · ownership.nature: These securities are directly held by the Coloma Family Trust (the "Family Trust"), for which the reporting person and his spouse serve as co-trustees.

Read SEC document
May 14, 2026 Filed May 18, 2026 21:03 UTC
Bernstein HaroldPresident, R&D & CMO
Exercise / conversionStock Option (Right to Buy) · Derivative 15,000 $0.00 Strike: $10.42 $0.00
Disclosure

SEC source: 0002050172-26-000021 · form4-05182026_090546.xml · derivative · entry 3

Bernstein Harold · CIK 0002050172 · President, R&D & CMO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 222,407

Underlying: Common Stock · 15,000 shares

Expires 2032-10-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.

F3 · derivative.exercise_date: The option vested as to 1/4th of the total award on October 3, 2023, and thereafter vested or vests as to 1/48th of the total award on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date.

Read SEC document
May 14, 2026 Filed May 18, 2026 21:03 UTC
Bernstein HaroldPresident, R&D & CMO
SaleCommon Stock 15,000 $26.22 $393,354.00
Disclosure

SEC source: 0002050172-26-000021 · form4-05182026_090546.xml · nonDerivative · entry 2

Bernstein Harold · CIK 0002050172 · President, R&D & CMO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.

F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.77 to $26.44 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
May 14, 2026 Filed May 18, 2026 21:03 UTC
Bernstein HaroldPresident, R&D & CMO
Exercise / conversionCommon Stock 15,000 $10.42 $156,300.00
Disclosure

SEC source: 0002050172-26-000021 · form4-05182026_090546.xml · nonDerivative · entry 1

Bernstein Harold · CIK 0002050172 · President, R&D & CMO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 15,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.

Read SEC document
May 04, 2026 Filed May 6, 2026 20:15 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 5,985 $0.00 Strike: $10.42 $0.00
Disclosure

SEC source: 0002050167-26-000010 · form4-05062026_080545.xml · derivative · entry 4

Dandekar Atul · CIK 0002050167 · CSBO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,725

Underlying: Common Stock · 5,985 shares

Expires 2033-03-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option vested or vests as to 1/48th of the total award monthly, with the first tranche vested on April 1, 2023, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date.

Read SEC document
May 04, 2026 Filed May 6, 2026 20:15 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 8,320 $0.00 Strike: $10.42 $0.00
Disclosure

SEC source: 0002050167-26-000010 · form4-05062026_080545.xml · derivative · entry 3

Dandekar Atul · CIK 0002050167 · CSBO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,204

Underlying: Common Stock · 8,320 shares

Expires 2032-03-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The option is fully vested. Pursuant to the terms of the reporting person's award agreement with the Issuer, the award became fully vested on February 1, 2026.

Read SEC document
May 04, 2026 Filed May 6, 2026 20:15 UTC Exercise / conversionCommon Stock 5,985 $10.42 $62,363.70
Disclosure

SEC source: 0002050167-26-000010 · form4-05062026_080545.xml · nonDerivative · entry 2

Dandekar Atul · CIK 0002050167 · CSBO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,808

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 04, 2026 Filed May 6, 2026 20:15 UTC Exercise / conversionCommon Stock 8,320 $10.42 $86,694.40
Disclosure

SEC source: 0002050167-26-000010 · form4-05062026_080545.xml · nonDerivative · entry 1

Dandekar Atul · CIK 0002050167 · CSBO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,823

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 04, 2026 Filed May 6, 2026 20:13 UTC GiftCommon Stock 7,422 $0.00 $0.00
Disclosure

SEC source: 0001192591-26-000002 · form4-05062026_080559.xml · nonDerivative · entry 1

HOMCY CHARLES J · CIK 0001192591 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,113

F1 · kind: The reported transaction represents a gift, for no consideration, which is exempt pursuant to Rule 16b-5.

F2 · balance_after: The total reflected in Column 5 of Table I includes shares which were previously held directly by the Charles J. Homcy Revocable Trust UA 11/4/1998.

Read SEC document
April 29, 2026 Filed May 1, 2026 20:18 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 7,500 $0.00 Strike: $10.42 $0.00
Disclosure

SEC source: 0002050167-26-000008 · form4-05012026_080517.xml · derivative · entry 3

Dandekar Atul · CIK 0002050167 · CSBO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 44,143

Underlying: Common Stock · 7,500 shares

Expires 2031-04-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.

F3 · derivative.exercise_date: The option is fully vested. Pursuant to the terms of the reporting person's award agreement with the Issuer, the award became fully vested on March 17, 2025.

Read SEC document
April 29, 2026 Filed May 1, 2026 20:18 UTC SaleCommon Stock 7,500 $25.37 $190,299.00
Disclosure

SEC source: 0002050167-26-000008 · form4-05012026_080517.xml · nonDerivative · entry 2

Dandekar Atul · CIK 0002050167 · CSBO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 10,503

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.

F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.08 to $25.77 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
April 29, 2026 Filed May 1, 2026 20:18 UTC Exercise / conversionCommon Stock 7,500 $10.42 $78,150.00
Disclosure

SEC source: 0002050167-26-000008 · form4-05012026_080517.xml · nonDerivative · entry 1

Dandekar Atul · CIK 0002050167 · CSBO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 18,003

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.

Read SEC document
April 01, 2026 Filed Apr 2, 2026 16:06 UTC
Bachrodt AmySVP, Finance
Exercise / conversionStock Option (Right to Buy) · Derivative 2,500 $0.00 Strike: $10.42 $0.00
Disclosure

SEC source: 0002050422-26-000012 · form4-04022026_080443.xml · derivative · entry 4

Bachrodt Amy · CIK 0002050422 · SVP, Finance

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 33,833

Underlying: Common Stock · 2,500 shares

Expires 2034-12-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.

F4 · derivative.exercise_date: The option vested or vests as to 1/48th of the total award monthly, with the first tranche vested on January 1, 2025, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date.

Read SEC document
April 01, 2026 Filed Apr 2, 2026 16:06 UTC
Bachrodt AmySVP, Finance
SaleCommon Stock 300 $30.34 $9,101.01
Disclosure

SEC source: 0002050422-26-000012 · form4-04022026_080443.xml · nonDerivative · entry 3

Bachrodt Amy · CIK 0002050422 · SVP, Finance

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 12,965

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.

F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.05 to $30.50 per share, inclusive.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.